Entera Bio Ltd To host key opinion leader webinar Transcript
Good morning, and welcome to the Entera Bio Key Opinion Leader Webinar on the treatment landscape for osteoporosis and EB613 potential impact. (Operator Instructions).
Before we begin, please note that this presentation, including all verbal remarks contain forward-looking statements, the accuracy of which depends on future events outside the company's control, and therefore, might cause actual results to differ materially from those forward-looking statements. In the case of any questions or discrepancies, we defer to the company's public documents available from its website and filed with the SEC.
I'd now like to turn the call over to Dr. John Bilezikian to take the presentation off. Please go ahead, Dr. Bilezikian.
Tara, thank you very much. It's a pleasure for me to join my colleagues in this presentation. My credentials are here. I'm a professional medicine at the Vagelos College of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |